8-K

CRH PUBLIC LTD CO 8-K Report (Oct 27, 2017)

Filed October 27, 2017For Securities:CRH

Summary

This 8-K filing from CRH PUBLIC LTD CO (CRH) reports on transactions involving persons discharging managerial responsibilities (PDMRs) and their closely associated persons. Specifically, it details transactions by Neil Colgan, the Company Secretary, and Joan Duffy, a person closely associated with Neil Colgan. These transactions occurred on October 25, 2017, and primarily involve the exercise of share options and the subsequent sale of ordinary shares. Investors should note that these are disclosures of insider transactions, providing transparency into the dealings of key personnel within the company.

Key Highlights

  • 1Disclosure of transactions by Neil Colgan, Company Secretary of CRH plc, on October 25, 2017.
  • 2Neil Colgan exercised options under CRH's Savings-related Share Option Scheme for 1,032 ordinary shares at a price of €17.67 per share.
  • 3Neil Colgan transferred 516 shares to his spouse at no cost.
  • 4Neil Colgan sold 516 ordinary shares at a price of €31.66 per share.
  • 5Disclosure of a transaction by Joan Duffy, a person closely associated with Neil Colgan.
  • 6Joan Duffy sold 516 ordinary shares at a price of €31.66 per share on October 25, 2017.
  • 7All transactions were conducted in Dublin, Ireland.

Frequently Asked Questions

The main purpose of this 8-K filing is to report transactions by persons discharging managerial responsibilities (PDMRs) and persons closely associated with them, as required by Article 19 of the Market Abuse Regulation (EU) No 596/2014. It provides transparency regarding insider dealings in CRH plc's ordinary shares.

Neil Colgan exercised options to acquire 1,032 ordinary shares at €17.67 each, transferred 516 of these shares to his spouse at no cost, and then sold 516 ordinary shares at €31.66 each. These transactions took place on October 25, 2017.

Yes, Joan Duffy, identified as a person closely associated with Neil Colgan, sold 516 ordinary shares at €31.66 each on the same date, October 25, 2017.

The price of €17.67 represents the exercise price for the share options, meaning Mr. Colgan paid this amount to acquire the shares from the company's option scheme. The price of €31.66 is the market price at which both Mr. Colgan and Ms. Duffy sold their shares, indicating the prevailing market value at the time of the sale.